Primary prevention of cardiovascular events in older adultsStatin therapy and blood pressure control have best evidence for primary prevention of cardiovascular events. Elderly women over-prescribedUBC study shows one in three elderly women inappropriately prescribed. Top 10 changes I'd like to see in Canada's new food guide Depression + metabolic risk factors boost chances of Type 2 diabetes Trial touts calorie restriction Adding a DPP-4 inhibitor to sulfonylurea therapy increases hypoglycemia risk by 50% Sulfonylurea dose should be reduced when starting a DPP-4 inhibitor in type 2 diabetes. Ready, Fire, Aim: The importance of validated learning Applying lean startup principles in a new pharmacy. Fasting not required for routine lipid profile tests Most lipid levels differ minimally when performed fasting or nonfasting. Study: 'Biggest Loser' contestants have slower metabolisms Updated Canadian diabetes guidelines for pharmacologic management of type 2 diabetes Empagliflozin should be added when glycemic targets are not met in patients with clinical cardiovascular disease. First Previous 107 108 109 110 111 Next Last
